OTCPK:BHIC (USA)
Â
Ordinary Shares
$
4.081
+0.041 (+1.01%)
10:08 PM EST
Business Description
BioScience Health Innovations Inc
NAICS : 456110
SIC : 5122
ISIN : US67012M1062
Share Class Description:
BHIC: Ordinary SharesTotal Employee Number:
1Description
BioScience Health Innovations Inc is engaged in full-scale operations as a distributor and generates revenue. The company's main business is to sell clinically tested, affordably priced products to naturally battle the onslaught of bacteria and viruses through online sales and various other distribution channels. The company develops, manufactures, and distributes science-backed nutritional supplements and delivery systems targeting cellular health, mitochondrial optimization, hormonal balance, and longevity.
Financial Strength
7/10
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
Cash-To-Debt | 2.49 | |||||
Equity-to-Asset | 0.72 | |||||
Debt-to-Equity | 0.27 | |||||
Debt-to-EBITDA | 7.42 | |||||
Interest Coverage | N/A |
N/A
|
N/A
| |||
Piotroski F-Score | 2/9 | |||||
Altman Z-Score | 46.67 | |||||
Beneish M-Score | -1.33 | |||||
WACC vs ROIC | ||||||
Growth Rank
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
3-Year Book Growth Rate | 138.1 |
Momentum Rank
5/10
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
5-Day RSI | 44.64 | |||||
9-Day RSI | 46 | |||||
14-Day RSI | 47.71 | |||||
3-1 Month Momentum % | 2.81 | |||||
6-1 Month Momentum % | 3.19 | |||||
12-1 Month Momentum % | 3.19 |
Liquidity Ratio
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
Current Ratio | 11.86 | |||||
Quick Ratio | 7.14 | |||||
Cash Ratio | 6.19 | |||||
Days Inventory | 74.56 | |||||
Days Sales Outstanding | 14.33 | |||||
Days Payable | 1.72 |
Dividend & Buy Back
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
3-Year Average Share Buyback Ratio | -100.4 | |||||
Shareholder Yield % | -0.94 |
Profitability Rank
2/10
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
Gross Margin % | 54.3 | |||||
Operating Margin % | 1.19 | |||||
Net Margin % | -0.29 | |||||
EBITDA Margin % | 1.19 | |||||
FCF Margin % | -14.1 | |||||
OCF Margin % | -13.58 | |||||
ROE % | -0.95 | |||||
ROA % | -0.78 | |||||
ROIC % | 8.46 | |||||
ROC (Joel Greenblatt) % | 11.62 | |||||
ROCE % | 3.73 | |||||
Years of Profitability over Past 10-Year | 2 | |||||
Moat Score | 2 |
GF Value Rank
2/10
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
PE Ratio | N/A |
N/A
|
N/A
| |||
PE Ratio without NRI | N/A |
N/A
|
N/A
| |||
PS Ratio | 8.76 | |||||
PB Ratio | 27.57 | |||||
Price-to-Tangible-Book | 29.15 | |||||
EV-to-EBIT | 740.4 | |||||
EV-to-EBITDA | 740.4 | |||||
EV-to-Revenue | 8.81 | |||||
EV-to-FCF | -62.46 | |||||
Price-to-GF-Value | 0.02 | |||||
Price-to-Projected-FCF | 408.1 | |||||
| Price-to-Net-Current-Asset-Value | 29.15 | |||||
| Price-to-Net-Cash | 102.03 | |||||
Earnings Yield (Greenblatt) % | 0.14 | |||||
FCF Yield % | -1.58 |
Operating Revenue by Business Segment
Operating Revenue by Geographic Region
Historical Operating Revenue by Business Segment
Historical Operating Revenue by Geographic Region
Guru Trades
See DetailsInsider Trades
See DetailsGurus Latest Trades with OTCPK:BHIC
You need a Premium membership or above to view this section.
Take a 7-Day Free Trial
No Available Data
Peter Lynch Chart
Performance
Dividend
Log
Bar
Annualized Return % Â
Total Annual Return % Â
BioScience Health Innovations Inc Executives
DetailsAnalyst Estimate
Key Statistics
| Name | Value | ||
|---|---|---|---|
| Revenue (TTM) (Mil $) | 5.212 | ||
| EPS (TTM) ($) | - | ||
| Beta | 2.5693 | ||
| 3-Year Sharpe Ratio | -0.19 | ||
| 3-Year Sortino Ratio | -0.27 | ||
| Volatility % | 158.83 | ||
| 14-Day RSI | 47.71 | ||
| 14-Day ATR ($) | 0.288513 | ||
| 20-Day SMA ($) | 4.169816 | ||
| 12-1 Month Momentum % | 3.19 | ||
| 52-Week Range ($) | 1.59 - 9.98 | ||
| Shares Outstanding (Mil) | 11.42 |
Piotroski F-Score Details
Year:
| Component | Result | ||
|---|---|---|---|
| Piotroski F-Score | 2 | ||
| Positive ROA | |||
| Positive CFROA | |||
| Higher ROA yoy | |||
| CFROA > ROA | |||
| Lower Leverage yoy | |||
| Higher Current Ratio yoy | |||
| Less Shares Outstanding yoy | |||
| Higher Gross Margin yoy | |||
| Higher Asset Turnover yoy |
BioScience Health Innovations Inc Filings
| Filing Date | Document Date | Form | ||
|---|---|---|---|---|
| No Filing Data | ||||
BioScience Health Innovations Inc Stock Events
| Event | Date | Price ($) | ||
|---|---|---|---|---|
| Third quarter earnings results for 2026 | 2026-10-27 | In 98 days | ||
| Second quarter earnings results for 2026 | 2026-08-07 | In 17 days | ||
| General meeting for 2025 | 2026-07-20 | 4.08 (+0.00%) | ||
| First quarter earnings results for 2026 | 2026-05-11 | 4.71 (+17.63%) | ||
| Annual report for 2025 | 2026-03-30 | 2.06 (+3.00%) | ||
| Third quarter earnings results for 2025 | 2025-10-27 | 4.00 (+0.00%) | ||
| 0.25:1 Stock Split | 2025-09-26 | 4.00 (+0.00%) | ||
| Second quarter earnings results for 2025 | 2025-08-07 | 4.00 (+0.00%) | ||
| First quarter earnings results for 2025 | 2025-05-08 | 52.00 (+0.00%) | ||
| Annual report for 2024 | 2025-03-13 | 52.00 (+0.00%) |
Show
Entries
BioScience Health Innovations Inc Frequently Asked Questions
What is BioScience Health Innovations Inc(BHIC)'s stock price today?
The current price of BHIC is $4.08. The 52 week high of BHIC is $9.98 and 52 week low is $1.59.
When is next earnings date of BioScience Health Innovations Inc(BHIC)?
The next earnings date of BioScience Health Innovations Inc(BHIC) is 2026-08-07 Est..
Does BioScience Health Innovations Inc(BHIC) pay dividends? If so, how much?
BioScience Health Innovations Inc(BHIC) does not pay dividend.
Guru Commentaries on OTCPK:BHIC
No articles.
Press Release
| Subject | Date | ||
|---|---|---|---|
| Rebelution Partners with Best 365 Labs and Growvana to Scale Science-Backed Cellular Health on Amazon and Beyond | 2026-03-12 |
Articles on BioScience Health Innovations Inc
No articles.
Survey
We'd love to learn more about your experiences on GuruFocus.com and how we can improve!
Take Survey
Follow Us
Disclaimers